A forthcoming HSE assessment will determine who qualifies for Mounjaro, with access likely restricted to high-risk patients due to cost

With Cork a crucial part of its global supply chain, Eli Lilly's weight loss drugs are shaking up an industry once ruled by Ozempic and Wegovy maker, Novo Nordisk

Experts in the US carried out a review and meta-analysis of 18 trials involving GLP-1 agonists on youngsters aged six to 17

Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing inches, though both drugs worked

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role beyond simply helping people shed pounds

If the treatment is approved for everyone eligible, the State’s drugs budget could more than double, a doctors’ conference heard

With dietary drugs on the rise and the food industry already seeing their effects, Irish dairy is assessing the impact they might have

Commonly-used antibiotic amoxicillin is also hard to come by, as are some ibuprofen tablets

Incorrect use of drugs such as Ozempic or Mounjaro can carry a big risk, writes Liz Dunphy

Pathologist Dr Margot Bolster said Breeda O’Donoghue's death should be referred to the Health Products Regulatory Authority

Finding semaglutide could benefit sufferers of condition that causes abscesses and scarring on the skin described as 'highly encouraging'

Semaglutides are powerful drugs that carry risks, not tools for rapid weight loss. We don’t know what the long-term health consequences will be

No previous medicine has ever challenged international culture, jolted the food industry into radical change, rattled the future prospects of the alcohol industry, threatened Big Tobacco or promised the possibility of cheaper air travel, writes Terry Prone

Health Products Regulatory Authority warns of shortage as the #Ozempic hashtag hits over a billion views on Tiktok